-
From Immune Phenotypes to Translational Decisions
2026-09-23
Multiparametric PBMC assays can reveal how small molecules shape immune function—but only when phenotypes are interpreted alongside mechanism, assay quality, and translational limits. Learn how curated compound collections can support more decision-ready inflammation research.
-
Pentoxifylline in Preterm Monocyte Hyperinflammation
2026-09-23
The reference study shows that Pentoxifylline suppresses LPS-driven inflammatory activation in monocytes from preterm and term infants, while also revealing age-dependent effects on surface markers, IL-10 production, and phagocytosis. Its combined flow-cytometry, cytokine, signaling, and RT-PCR design provides a useful framework for studying immunomodulation in neonatal sepsis models without equating in vitro activity with clinical efficacy.
-
BX795 Connects PDK1, TBK1, and Translational Strategy
2026-09-22
BX795 is more than an ATP-competitive PDK1 inhibitor: its activity against TBK1 and IKKε makes it a powerful tool for connecting PI3K/Akt/mTOR biology with IRF3-dependent innate immune signaling. This article translates recent HBV–TBK1–autophagy findings into a practical framework for assay design, target attribution, and translational decision-making.
-
DiscoveryProbe Immunology/Inflammation Library
2026-09-22
The DiscoveryProbe Immunology/Inflammation Compound Library supports a decision-oriented approach to immunomodulator screening, combining curated pharmacology with multiplex PBMC phenotyping. This guide explains how to distinguish pathway-specific immune modulation from cytotoxicity and convert multidimensional results into stronger inflammation target validation.
-
Pentoxifylline Workflows for Inflammation Research
2026-09-21
Build reproducible Pentoxifylline assays by connecting PDE inhibition, cAMP signaling, cytokine measurements, and disease-relevant immune models. This practical guide covers PBMC and macrophage workflows, translational study design, formulation, and troubleshooting.
-
KDM3A–METTL16–PDK1 Axis in TKI Resistance
2026-09-21
The reference study identifies a coordinated epigenetic and post-transcriptional mechanism that elevates PDK1 and promotes resistance to gefitinib and osimertinib. Its findings connect KDM3A-mediated histone demethylation with METTL16-dependent m6A modification and IGF2BP1-mediated stabilization of PDK1 mRNA, providing a mechanistic framework for combination treatment strategies.
-
TMEM16F in Kupffer Cells Protects Against Listeria
2026-09-20
Tang et al. show that TMEM16F protects against Listeria monocytogenes primarily through its activity in liver Kupffer cells rather than T or B cells. The study links TMEM16F-dependent plasma-membrane repair to reduced Kupffer-cell death, controlled liver inflammation, and preservation of hepatic metabolism, providing a cell-specific framework for studying infection-associated tissue injury.
-
Methylprednisolone Workflows for Inflammation and Bone
2026-09-19
Methylprednisolone supports controlled studies of glucocorticoid signaling, cytokine regulation, and steroid-associated bone injury. This guide connects practical in vitro anti-inflammatory assays with a validated rat model of femoral-head osteonecrosis, while emphasizing formulation, controls, and endpoint selection.
-
JNK-IN-7 for Mechanistic Apoptosis Assays
2026-09-18
JNK-IN-7 is a selective JNK inhibitor for separating c-Jun signaling from downstream apoptosis in infection, inflammation, and innate immune models. Its covalent JNK engagement and defined DMSO handling support phase-resolved experiments in bovine mammary epithelial cells and macrophage-based assays.
-
v-Agatoxin-IVA and N-Type Ca Channel Blockade
2026-09-18
Sidach and Mintz showed that v-Agatoxin-IVA remains a high-affinity P-type calcium-channel blocker but can also produce weaker, voltage-dependent inhibition of neuronal N-type channels. The study refines the pharmacological separation of P-, Q-, and N-type currents and highlights why toxin concentration and membrane potential are critical for interpreting selectivity.
-
Nitrocefin Assays: From Signal to Resistance Biology
2026-09-17
Nitrocefin is a chromogenic cephalosporin substrate that converts β-lactamase activity into a measurable color signal. This guide explains how to interpret that signal, connect it with GOB-38 resistance biology, and design more informative biochemical assays.
-
NLRP3-Driven Astrocyte Remodeling in Morphine Tolerance
2026-09-17
Yuan et al. connect NLRP3 inflammasome activation with a shift toward the A1 reactive astrocyte phenotype during morphine tolerance. Their pharmacological intervention study indicates that MCC950 slows tolerance development while normalizing spinal inflammatory and astrocyte-associated markers, although the findings remain mechanistic rather than definitive proof of astrocyte-specific causality.
-
JNK-IN-7: Selective JNK Inhibitor for Apoptosis
2026-09-16
JNK-IN-7 enables pathway-level dissection of c-Jun phosphorylation, inflammatory signaling, and apoptosis with low-nanomolar activity across JNK1, JNK2, and JNK3. Its value is especially strong in infection models where fungal morphology, cell type, and exposure level can redirect the dominant death pathway.
-
Pentoxifylline, Rolipram, and Macrophage NO
2026-09-16
The reference study shows that the phosphodiesterase inhibitors Pentoxifylline and rolipram suppress inducible nitric oxide production in activated macrophages through a cAMP-associated reduction in iNOS expression. Its combined in vitro, mechanistic, and in vivo design provides a useful framework for evaluating PDE-directed anti-inflammatory activity while also highlighting the substantial potency difference between the two compounds.
-
Isochlorogenic acid A Research Workflows
2026-09-15
Translate Isochlorogenic acid A from a water-insoluble natural product into solvent-controlled antibacterial, cell-migration, and hydrogel studies. A recent Fe(III)-coassembled nanoparticle workflow shows how formulation can connect anti-infection research with inflammation and wound-repair readouts.